Global Acne Market 2014-2018

Global Acne Market 2014-20180280035Acne or acne vulgaris is an inflammatory disorder of the skin which affects people of almost all age groups. The exact etiology of acne is not fully understood. Although acne does not present a serious threat to health, severe acne can not only be painful but also affect a person’s quality of life. Topical medications, oral medications, or a combination of both are some of the treatment options available for acne. Covered in this Report0280035This report covers the present scenario and the growth prospects of the Global Acne market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs and topical creams used in the treatment of acne that are available in the market.
The report also presents the vendor landscape and a corresponding detailed analysis of the top five vendors in the Global Acne market. In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.
View our full TOC hereKey Regions
EMEA
APAC
Americas
Key Vendors
Actavis plc
Allergen Inc.
Galderma S.A.
Stiefel Laboratories Inc.
Valeant Pharmaceuticals International Inc.
Other Prominent Vendors
Andro Science
Bayer
Cipher Pharmaceuticals
Cosmo Pharmaceuticals
EloracFoamixHelix BioMedixHygeia Therapeutics
IMTM
J&J
Mylan Pharmaceuticals
NanoBio
NovaLead Pharma
Roche
Key Market Driver
Significant Unmet Need
For a full, detailed list, view our report.
Key Market Challenge
Increase in Number of Alternative Treatments
For a full, detailed list, view our report.
Key Market Trend
Increased Focus on Combination Therapies
For a full, detailed list, view our report.
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key